A previous study has shown that ZnR/GPR39 mediates the Zn2+-dependent activation of mitogen-activated protein kinase (MAPK) and PI3K, to induce S100A4 expression and prostate cancer cell invasiveness [129]. The gene discussed is S100A4; the disease is prostate cancer.